Mesenchymal stem cells: immune evasive, not immune privileged

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Biotechnology

• Publication date

  2014-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nbt.2816PMID 24561556PMCID PMC4320647
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineering cells with intracellular agent–loaded microparticles to control cell phenotype

  2014cited by this paper
• Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.

  2014cited by this paper
• mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation.

  2013cited by this paper
• Encapsulated mesenchymal stem cells for in vivo immunomodulation

  2013cited by this paper
• Mesenchymal stromal cells: sensors and switchers of inflammation.

  2013cited by this paper
• Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer.

  2013cited by this paper
• Stricter standards sought to curb stem-cell confusion

  2013cited by this paper
• Adipose Tissue‐Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow‐Derived Counterparts

  2013cited by this paper
• Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

  2013cited by this paper
• The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine

  2013cited by this paper
• Anti‐donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

  2013cited by this paper
• Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding.

  2013cited by this paper
• Concise Review: Two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation

  2013cited by this paper
• Induction of Tolerance of Vascularized Composite Allografts

  2013cited by this paper
• Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.

  2013cited by this paper
• Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells

  2013cited by this paper
• MSCs: science and trials

  2013cited by this paper
• MSCs: science and trials

  2013cited by this paper
• Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease

  2013cited by this paper
• MSCs: science and trials

  2013cited by this paper
• Treatment with mesenchymal stromal cells is a risk factor for pneumonia‐related death after allogeneic hematopoietic stem cell transplantation

  2012cited by this paper
• Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

  2012cited by this paper
• Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

  2012cited by this paper
• Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

  2012cited by this paper
• How mesenchymal stem cells interact with tissue immune responses.

  2012cited by this paper
• Toll-Like Receptors as Modulators of Mesenchymal Stem Cells

  2012cited by this paper
• Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long‐Term Engraftment and No Ectopic Tissue Formation

  2012cited by this paper
• Perivascular cells for regenerative medicine

  2012cited by this paper
• Mesenchymal stem cells are injured by complement after their contact with serum.

  2012cited by this paper
• NCATS launches drug repurposing program

  2012cited by this paper
• Hematopoietic stem cell heterogeneity takes center stage.

  2012cited by this paper
• Mesenchymal stromal cells: new directions.

  2012cited by this paper
• Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration.

  2012cited by this paper
• Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

  2012cited by this paper
• Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

  2012cited by this paper
• Modulation of Human Mesenchymal Stem Cell Immunogenicity through Forced Expression of Human Cytomegalovirus US Proteins

  2012cited by this paper
• Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.

  2012cited by this paper
• Multipotent mesenchymal stromal cells and the innate immune system

  2012cited by this paper
• An Abundant Perivascular Source of Stem Cells for Bone Tissue Engineering

  2012cited by this paper
• Canada approves stem cell product

  2012cited by this paper
• Immunogenicity of allogeneic mesenchymal stem cells

  2012cited by this paper
• Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy.

  2012cited by this paper
• Adventitial Delivery of an Allogeneic Bone Marrow–Derived Adherent Stem Cell in Acute Myocardial Infarction: Phase I Clinical Study

  2012cited by this paper
• Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal Cells

  2012cited by this paper
• Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation

  2011cited by this paper
• Cell-surface sensors for real-time probing of cellular environments.

  2011cited by this paper
• Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses

  2011cited by this paper
• Exploitation of Herpesvirus Immune Evasion Strategies to Modify the Immunogenicity of Human Mesenchymal Stem Cell Transplants

  2011cited by this paper
• South Korea's stem cell approval

  2011cited by this paper
• The MSC: an injury drugstore.

  2011cited by this paper
• Cellular and extracellular programming of cell fate through engineered intracrine-, paracrine-, and endocrine-like mechanisms.

  2011cited by this paper
• EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS Concise Review: Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells: Progress Toward Safe Clinical Products

  2011cited by this paper
• Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli.

  2010cited by this paper
• Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.

  2010cited by this paper
• Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting.

  2010cited by this paper
• High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

  2010cited by this paper
• Mesenchymal Stem Cell and Islet Co-Transplantation Promotes Graft Revascularization and Function

  2010cited by this paper
• Mesenchymal stem cell therapy: Two steps forward, one step back.

  2010cited by this paper
• A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype

  2010cited by this paper
• Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs.

  2010cited by this paper
• Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance

  2009cited by this paper
• Targeting mesenchymal stem cells to activated endothelial cells.

  2009cited by this paper
• Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells.

  2009cited by this paper
• Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.

  2009cited by this paper
• Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells

  2009cited by this paper
• Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6.

  2009cited by this paper
• Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease

  2009cited by this paper
• Fate Of Culture-Expanded Mesenchymal Stem Cells in The Microvasculature: In Vivo Observations of Cell Kinetics

  2009cited by this paper
• Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression

  2009cited by this paper
• Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors

  2009cited by this paper
• Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging

  2009cited by this paper
• Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.

  2009cited by this paper
• Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells1

  2008cited by this paper
• Chemical engineering of mesenchymal stem cells to induce a cell rolling response.

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Immunomodulatory properties of mesenchymal stromal cells.

  2007cited by this paper
• Although Pig Allogeneic Mesenchymal Stem Cells Are Not Immunogenic In Vitro, Intracardiac Injection Elicits an Immune Response In Vivo

  2007cited by this paper
• Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response.

  2007cited by this paper
• Immunologic Consequences of Multiple, High-Dose Administration of Allogeneic Mesenchymal Stem Cells to Baboons

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006cited by this paper
• Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.

  2006cited by this paper
• Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma.

  2006cited by this paper
• Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell.

  2006cited by this paper
• T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.

  2005cited by this paper
• Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes.

  2005cited by this paper
• Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

  2005cited by this paper
• Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.

  2004cited by this paper
• Current concepts review: Engineering principles of clinical cell-based tissue engineering

  2004cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004cited by this paper
• Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice.

  2004cited by this paper
• Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex

  2003cited by this paper
• Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

  2003cited by this paper
• Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

  2003cited by this paper
• A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts1

  2003cited by this paper
• A short course of mycophenolate immunosuppression inhibits rejection, but not tolerance, of rat liver allografts in association with inhibition of interleukin-4 and alloantibody responses

  2003cited by this paper
• HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

  2003cited by this paper
• Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.

  2002cited by this paper
• Mesenchymal Stem Cells

  2002cited by this paper
• Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

  2002cited by this paper
• Cell surface engineering by a modified Staudinger reaction.

  2000cited by this paper

• Mesenchymal stem cells alleviate experimental cerebral malaria disease severity by inducing RoRγt+ Foxp3+ T regulatory (Tr 17) cells and modulating the dysregulated Th17/Treg axis

  2026cites this paper
• New and Emerging Therapies Related to Rheumatoid Arthritis

  2026cites this paper
• Advances in stem cell–derived beta-cell therapy: A new frontier in type 1 diabetes treatment

  2026cites this paper
• Biomimetic Multifunctional Scaffolds for Osteochondral Regeneration: Bridging Material Design and Functional Integration.

  2026cites this paper
• Mesenchymal Stem/Stromal Cell-Free Therapies: Challenges and Opportunities.

  2026cites this paper
• Artificially constructed collagen-targeting receptors on mesenchymal stromal cells promote anoikis resistance and tissue repair.

  2026cites this paper
• A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancer

  2026cites this paper
• Glia‐to‐Axon Transfer of Ribosomes and miRNAs: A Novel Paradigm in Neural Repair

  2026cites this paper
• Characterization and priming of equine muscle-derived mesenchymal stem cells to enhance their anti-inflammatory and immunomodulatory profiles

  2026influential citation
• Revisión narrativa: células madre mesenquimales de cordón umbilical y osteoartritis

  2026cites this paper
• Narrative review: Mesenchymal stem cells derived from the umbilical cord and osteoarthritis

  2026cites this paper
• Application of IFN-γ-Licensed urine-derived stem cells in SIS hydrogel promotes scar-free wound healing by immunomodulation and microenvironment remodeling

  2026cites this paper
• Stem cell therapy in thin endometrium and Asherman's syndrome: a systematic review and meta-analysis.

  2026cites this paper
• A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment

  2026cites this paper
• Advances in MicroRNA-Based Therapies for Cardiac Repair: Emerging Strategies for Treating Myocardial Infarction.

  2026cites this paper
• Hepatocyte-like cell therapy for end-stage liver disease: From basic science to clinical application

  2026cites this paper
• Mesenchymal stem cells and the central nervous system: historical perspectives and future directions

  2026cites this paper
• TriCAN: A phase-transition molecular robot realizing closed-loop sense-compute-actuate control for inflammation-triggered bone regeneration

  2026cites this paper
• Therapeutic potential of MSCs and their exosomes in hepatic Ischaemia-Reperfusion injury: a systematic review and meta-analysis of rodent studies

  2026cites this paper
• Therapeutic Efficacy of Mesenchymal Stem Cells (MSCs) on Alzheimer's Disease: Review of Clinical Results.

  2026cites this paper
• The role of stromal cell immunobiology in understanding and managing Sjögren's disease.

  2026cites this paper
• Stem Cell-Derived Exosomes for Diabetic Wound Healing: Mechanisms, Nano-Delivery Systems, and Translational Perspectives

  2026cites this paper
• Characterization, Preconditioning, Safety, and Other Issues of MSC-Derived EVs and Secretome.

  2026cites this paper
• Advanced Therapy Medicinal Products: Emerging Therapeutic Frontiers and Evolving Regulatory Landscapes.

  2026cites this paper
• Mesenchymal Stem Cells With Adjuvant Dexamethasone in Patients With Alzheimer’s Disease: A Phase IIa Trial

  2025cites this paper
• Results from the SCIENCE and Danish ASC trials using allogeneic mesenchymal stromal cells to treat ischemic heart failure patients

  2025cites this paper
• The Impact of IFN-γ Licensing on Mesenchymal Stromal Cells’ Mediated Immunoregulation and HLA Class II Expression: Emerging Evidence from In Vitro Results

  2025cites this paper
• Allogeneic Gene Therapy with BMP-2 Transduced Mesenchymal Stem Cells Combined with Immunosuppression: Enhanced Bone Healing in a Rat Critical Sized Femoral Defect Model.

  2025cites this paper
• Mesenchymal stromal cell therapy for scarring: a systematic review of clinical and preclinical studies.

  2025cites this paper
• Intra-articular delivery of allogeneic bone marrow derived mesenchymal stromal cells (BM-MSCs) for painful lumbar facet arthropathy: a phase I clinical trial

  2025cites this paper
• Cell Transplantation Techniques for Cartilage Restoration.

  2025cites this paper
• Immunomodulatory properties of mesenchymal stem cells within three-dimensional collagen matrices

  2025cites this paper
• Application of Dental Pulp Stem Cell-Derived Intracellular Vesicles for Diabetic Wound Healing.

  2025cites this paper
• Impact of cigarette smoke on the functions of mesenchymal stem cells

  2025cites this paper
• Wharton's Jelly Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Attenuate Intervertebral Disc Degeneration Under Inflammatory Stress in an In Vitro 3D Culture System

  2025cites this paper
• Therapeutic effects of mesenchymal stem cells on traumatic brain injury: a bibliometric study in CiteSpace

  2025cites this paper
• Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies

  2025cites this paper
• Injectable co-assembled microgels for programmed endogenous regeneration of nucleus pulposus

  2025cites this paper
• Hydrogel microcapsulation technology reduces the DMSO concentration required for stem cell cryopreservation

  2025cites this paper
• Comparative cardiomyocyte differentiation potential of rat adipose-derived mesenchymal stem cells from two anatomical sites: metabolomic profiling and pathway analysis

  2025cites this paper
• Persistent Stimulation of Human Mesenchymal Stem/Stromal Cells with TNF-α and IFN-γ Affects the Release of Large Extracellular Vesicles with Immunoregulatory Phenotype

  2025cites this paper
• Sex‐Dependent Paracrine Effect of Conditioned Media From Adipose Tissue Derived Mesenchymal Stem Cells on Prostate Cancer Cells

  2025cites this paper
• Towards Extracellular Vesicles in the Treatment of Epidermolysis Bullosa

  2025cites this paper
• Strong Immune Privileges of MSC and Other Nes-GFP+ Progenitors in Bone Marrow of Transgenic Mice

  2025cites this paper
• Comment on: Efficacy and safety of culture-expanded mesenchymal stromal cell therapy in the treatment of 4 types of inflammatory arthritis: A systematic review and meta-analysis of 36 randomized controlled trials.

  2025cites this paper
• Stem cells in the treatment of myocardial injury-induced cardiomyopathy: mechanisms and efficient utilization strategies

  2025cites this paper
• Targeting ferroptosis in spinal cord injury through stem cell therapy: mechanisms and therapeutic prospects

  2025cites this paper
• Adipose-derived mesenchymal stem cells for the prevention of capsular contracture

  2025cites this paper
• Aging Adipose‐Derived Mesenchymal Stem Cells, Cultured on a Native Young Extracellular Matrix, Are Protected From Senescence and Apoptosis Along With Increased Expression of HLA‐DR and CD74 Associated With PI3K Signaling

  2025cites this paper
• Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges

  2025cites this paper
• Beyond Biomaterials: Engineering Bioactive Hydrogels as Immuno-Mechanobiological Niches for Osteochondral Regeneration

  2025cites this paper
• Exploring the therapeutic potential of MSC-derived secretomes in neonatal care: focus on BPD and NEC

  2025cites this paper
• MHC compatibility influences the interaction between different types of equine mesenchymal stem/stromal cells and the local immune response.

  2025cites this paper
• Cell and Hydrogel‐Integrated Therapies for Intervertebral Disc Regeneration

  2025cites this paper
• Innate Immune‐Cloaked Microgel‐Coated Mesenchymal Stromal Cells Reverse Persistent Pulmonary Fibrosis via Reparative Macrophages

  2025cites this paper
• Injectable Immune-Regulating Mesenchymal Stem Cells Hydrogel for Localized Scleroderma Treatment.

  2025cites this paper
• Roles of TGF-β in the therapeutic potential of hypoxic mesenchymal stem cells for treating osteoarthritis in a Rabbit model

  2025cites this paper
• Mesenchymal stem cell implantation mitigates ionizing radiation-induced vascular damage in the murine aorta

  2025cites this paper
• Extracellular vesicles derived from menstrual blood-derived mesenchymal stem cells suppress inflammatory atherosclerosis by inhibiting NF-κB signaling

  2025cites this paper
• Comments on "Adipose stem cells prevent esophageal strictures after extensive endoscopic submucosal dissection - experimental research".

  2025cites this paper
• Prospective Double-Blind Randomized Study of Single Dose Bone Marrow-Derived Mesenchymal Stromal Cells versus Placebo for Steroid-Refractory Acute Graft-Versus-Host Disease.

  2025cites this paper
• CRISPR-mediated engineering of mesenchymal stromal/stem cells: a summary of recent progress in immunological applications for regenerative medicine and cancer therapy

  2025cites this paper
• Cell therapies against brain tumors: Clinical development and emerging prospects

  2025cites this paper
• Advances in cell therapy for orthopedic diseases: bridging immune modulation and regeneration

  2025cites this paper
• Combined rapamycin and mesenchymal stem/stromal cells derived from induced pluripotent stem cells-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva

  2025cites this paper
• Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation

  2025cites this paper
• Functionalized extracellular vesicles of mesenchymal stem cells for regenerative medicine

  2025cites this paper
• Cellular therapies for the prevention and treatment of acute graft-versus-host disease.

  2025cites this paper
• Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants

  2025cites this paper
• The Emerging Role of Extracellular Vesicle-Derived lncRNAs and circRNAs in Tumor and Mesenchymal Stem Cells: The Biological Functions and Potential for Clinical Application

  2025cites this paper
• Effects of Dexamethasone and Tacrolimus on Mesenchymal Stem Cell Characteristics and Gene Expression

  2025cites this paper
• Immune modulatory stem cells represent a significant component of the immune system

  2025cites this paper
• Exploring the Differentiation Abilities of Hair Follicle and Dental Pulp Stem Cells Into Islet Like Cells

  2025cites this paper
• KLF5 enhances CXCL12 transcription in adipose-derived stem cells to promote endothelial progenitor cells neovascularization and accelerate diabetic wound healing

  2025cites this paper
• The role of the immune system in osteoarthritis: mechanisms, challenges and future directions

  2025cites this paper
• Multiple Intra-Articular Injections of Adipose-Derived Mesenchymal Stem Cells for Canine Osteoarthritis Treatment

  2025cites this paper
• Investigational New Drug-enabling studies to use genetically modified mesenchymal stromal cells in patients with critical limb ischemia

  2025cites this paper
• Impact of Intranasal Administration of Fresh Breast Milk in Very Low Birth Weight Infants With Germinal Matrix-Intraventricular Hemorrhage

  2025cites this paper
• Calciphylaxis: ongoing challenges and treatment opportunities with mesenchymal stem cells

  2025cites this paper
• Enabling Mesenchymal Stromal Cells and Their Extracellular Vesicles Clinical Availability—A Technological and Economical Evaluation

  2025influential citation
• Clinical translation of mesenchymal stem cells in ischemic heart failure: Challenges and future perspectives.

  2025cites this paper
• Stem cell-based therapies and organoid models: Advancing tuberculosis treatment and research

  2025cites this paper
• Identification of the crucial roles of BAXhigh NK cells in human derived mesenchymal stem cell therapy for chronic heart failure patients.

  2025cites this paper
• Stem cell injections for osteoarthritis of the knee.

  2025cites this paper
• The inconclusive superiority debate of allogeneic versus autologous MSCs in treating patients with HFrEF: a systematic review and meta-analysis of RCTs

  2025cites this paper
• Stem cell-based therapeutic strategies for liver aging

  2025cites this paper
• Progress of mesenchymal stem cell-derived exosomes in targeted delivery of antitumor drugs

  2025cites this paper
• DSUP modified mesenchymal stem cells exert significant radiation protective effect by enhancing the hematopoietic niche

  2025cites this paper
• Specifically Enhanced Immunosuppression of B Cells with Chimeric Antigen Receptors Modify Mesenchymal Stem Cells

  2025cites this paper
• Genetic modification of mesenchymal stem cells (MSCs): novel strategy to expand their naïve applications in critical illness

  2025cites this paper
• Intradiscal Mesenchymal Stromal Cell Therapy for the Treatment of Low Back Pain Due to Moderate‐to‐Advanced Multilevel Disc Degeneration: A Preliminary Report of a Double‐Blind, Phase IIB Randomized Clinical Trial (DREAM Study)

  2025cites this paper
• Small extracellular vesicles from human bone marrow mesenchymal stromal cells enhance migration and regulate reparative gene expression in dermal fibroblasts

  2025cites this paper
• The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review

  2025cites this paper
• Stem Cell-Derived Extracellular Vesicles in Skin Antiaging Treatments.

  2025cites this paper
• Therapeutic Engineering and Drug Loading of MSC-Exosomes for Oncological Applications

  2025cites this paper
• Regenerative strategies for intervertebral disc degeneration

  2025cites this paper
• Temporal dynamics of ADSC therapy in skin fibrosis: unraveling the roles of ROS/NF-κB/TSG-6 signaling axis

  2025cites this paper
• Selective MicroRNA Packaging Reveals Distinct Core Signatures in Human Mesenchymal-Stromal-Cell-Derived Extracellular Vesicles

  2025cites this paper
• Bone marrow-derived mesenchymal stromal cells in necrotizing enterocolitis treatment: a narrative review

  2025cites this paper
• Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Autoimmune Diseases

  2025cites this paper